Cargando…
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
BACKGROUND: The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda are not well known; however, this information is crucial to shaping the country’s public health approach to hepatitis C control. METHODS: A HCV screening campaign was conducted in the general population in...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683524/ https://www.ncbi.nlm.nih.gov/pubmed/31382901 http://dx.doi.org/10.1186/s12879-019-4322-7 |
_version_ | 1783442111825182720 |
---|---|
author | Makuza, Jean Damascene Liu, Carol Y. Ntihabose, Corneille Killy Dushimiyimana, Donatha Umuraza, Sabine Nisingizwe, Marie Paul Umutesi, Justine Serumondo, Janvier Mugeni, Soline Dusabeyesu Semakula, Muhamed Gupta, Neil Hellard, Margaret Nsanzimana, Sabin |
author_facet | Makuza, Jean Damascene Liu, Carol Y. Ntihabose, Corneille Killy Dushimiyimana, Donatha Umuraza, Sabine Nisingizwe, Marie Paul Umutesi, Justine Serumondo, Janvier Mugeni, Soline Dusabeyesu Semakula, Muhamed Gupta, Neil Hellard, Margaret Nsanzimana, Sabin |
author_sort | Makuza, Jean Damascene |
collection | PubMed |
description | BACKGROUND: The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda are not well known; however, this information is crucial to shaping the country’s public health approach to hepatitis C control. METHODS: A HCV screening campaign was conducted in the general population in 24 districts previously identified to have a high HCV disease burden. At the time of sample collection, sociodemographic information and self-reported risk factors were collected. Bivariate and multivariate logistic regressions were conducted to assess risk factors independently associated with hepatitis C antibodies (HCVAb) seroprevalence. RESULTS: Out of a total of 326,263 individuals screened for HCVAb, 22,183 (6.8%) were positive. In multivariate analysis, risk factors identified as statistically associated with HCVAb Seroprevalence include history of traditional operation or scarification (OR = 1.09, 95% CI: 1.05–1.14), presence of viral hepatitis in the family (OR = 1.27, 95% CI: 1.15–1.40), widowed or separated/divorced (OR = 1.36, 95% CI: 1.26–1.47), Southern province (OR = 1.98, 95% CI: 1.88–2.08) and aged 65 years and older (OR = 4.86, 95% CI: 4.62–5.11). Ubudehe category 3 (OR = 0.97, 95% CI: 0.93–1.01) and participants using RAMA (Health insurances for employees of public and private sectors) insurance (OR = 0.76, 95% CI: 0.70–0.85) had lower odds of HCV seroprevalence. CONCLUSIONS: Our findings provide important information for Rwanda’s strategy on prevention and case-finding. Future prevention interventions should aim to reduce transmission through targeted messaging around traditional healing practices and case-finding targeting individuals with a history of exposure or advanced age. |
format | Online Article Text |
id | pubmed-6683524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66835242019-08-09 Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program Makuza, Jean Damascene Liu, Carol Y. Ntihabose, Corneille Killy Dushimiyimana, Donatha Umuraza, Sabine Nisingizwe, Marie Paul Umutesi, Justine Serumondo, Janvier Mugeni, Soline Dusabeyesu Semakula, Muhamed Gupta, Neil Hellard, Margaret Nsanzimana, Sabin BMC Infect Dis Research Article BACKGROUND: The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda are not well known; however, this information is crucial to shaping the country’s public health approach to hepatitis C control. METHODS: A HCV screening campaign was conducted in the general population in 24 districts previously identified to have a high HCV disease burden. At the time of sample collection, sociodemographic information and self-reported risk factors were collected. Bivariate and multivariate logistic regressions were conducted to assess risk factors independently associated with hepatitis C antibodies (HCVAb) seroprevalence. RESULTS: Out of a total of 326,263 individuals screened for HCVAb, 22,183 (6.8%) were positive. In multivariate analysis, risk factors identified as statistically associated with HCVAb Seroprevalence include history of traditional operation or scarification (OR = 1.09, 95% CI: 1.05–1.14), presence of viral hepatitis in the family (OR = 1.27, 95% CI: 1.15–1.40), widowed or separated/divorced (OR = 1.36, 95% CI: 1.26–1.47), Southern province (OR = 1.98, 95% CI: 1.88–2.08) and aged 65 years and older (OR = 4.86, 95% CI: 4.62–5.11). Ubudehe category 3 (OR = 0.97, 95% CI: 0.93–1.01) and participants using RAMA (Health insurances for employees of public and private sectors) insurance (OR = 0.76, 95% CI: 0.70–0.85) had lower odds of HCV seroprevalence. CONCLUSIONS: Our findings provide important information for Rwanda’s strategy on prevention and case-finding. Future prevention interventions should aim to reduce transmission through targeted messaging around traditional healing practices and case-finding targeting individuals with a history of exposure or advanced age. BioMed Central 2019-08-05 /pmc/articles/PMC6683524/ /pubmed/31382901 http://dx.doi.org/10.1186/s12879-019-4322-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Makuza, Jean Damascene Liu, Carol Y. Ntihabose, Corneille Killy Dushimiyimana, Donatha Umuraza, Sabine Nisingizwe, Marie Paul Umutesi, Justine Serumondo, Janvier Mugeni, Soline Dusabeyesu Semakula, Muhamed Gupta, Neil Hellard, Margaret Nsanzimana, Sabin Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program |
title | Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program |
title_full | Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program |
title_fullStr | Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program |
title_full_unstemmed | Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program |
title_short | Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program |
title_sort | risk factors for viral hepatitis c infection in rwanda: results from a nationwide screening program |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683524/ https://www.ncbi.nlm.nih.gov/pubmed/31382901 http://dx.doi.org/10.1186/s12879-019-4322-7 |
work_keys_str_mv | AT makuzajeandamascene riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT liucaroly riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT ntihabosecorneillekilly riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT dushimiyimanadonatha riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT umurazasabine riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT nisingizwemariepaul riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT umutesijustine riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT serumondojanvier riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT mugenisolinedusabeyesu riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT semakulamuhamed riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT guptaneil riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT hellardmargaret riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram AT nsanzimanasabin riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram |